Surviving Daily Life
Launched by THOMAS JEFFERSON UNIVERSITY · Jun 27, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Surviving Daily Life," is looking at how breast cancer survivors experience daily stress and changes in thinking or memory. The study aims to see if using a short, 14-day mobile diary is a good way to track these daily feelings and mental performance. The researchers want to make sure the questions in the diary are reliable and meaningful for women who have survived breast cancer.
Women who might be eligible for this study are those who are 40 years or older, were diagnosed with breast cancer at least five years ago, and identify as Asian, Black, Latina, or white. Participants need to be able to read English, Spanish, or Chinese, as the diary will be available in these languages. If you join, you will be asked to complete a daily survey on your phone for two weeks, sharing your experiences with stress and how your thinking feels each day. This study is currently not recruiting but is open to patients from the Sidney Kimmel Comprehensive Cancer Center.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- Individuals must meet all of the following inclusion criteria in order to be eligible to participate in the study:
- • Individuals 40 or older
- • Five or more years after breast cancer diagnosis
- • Self-identified as Asian, Black, Latina, or white
- • Able to read in English, Spanish, or Chinese
- Exclusion Criteria:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- • Under 40
- • Cannot provide informed consent
About Thomas Jefferson University
Thomas Jefferson University is a distinguished academic institution located in Philadelphia, Pennsylvania, renowned for its commitment to advancing healthcare through research and education. As a clinical trial sponsor, the university leverages its extensive resources and interdisciplinary expertise to conduct innovative research aimed at improving patient outcomes. With a focus on translational medicine, Thomas Jefferson University collaborates with various stakeholders, including healthcare professionals, industry partners, and regulatory agencies, to ensure the highest standards of scientific rigor and ethical conduct in its clinical trials. The institution is dedicated to fostering a culture of excellence in research, ultimately contributing to the advancement of medical knowledge and the development of novel therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ana Maria Lopez, MD
Principal Investigator
Thomas Jefferson University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported